KOREA
Manufacturer
F05
Antisense, RNA, Biopharmaceuticals (general category), CMC
BIORCHESTA strives to develop disease-modifying therapies in neurodegenerative diseases by focusing on novel RNA therapeutics and brain drug delivery technology to solve the greatest challenges faced in CNS diseases for patients and their families to provide them with a significantly improved quality of life.
